Pascal Biosciences to Present at International Cannabinoid Derived Pharmaceutical Summit

Author's Avatar
Sep 16, 2020
Article's Main Image

SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / September 16, 2020 / Pascal Biosciences Inc. (TSXV:PAS, Financial) ("Pascal") has been invited to present at the International Cannabinoid Derived Pharmaceutical (ICDP) Summit. Today Dr. Patrick Gray, CEO of Pascal Biosciences, will present advancements in each of Pascal's three cannabinoid programs. The title of his presentation is "Identifying and Validating Mechanism of Action In Vivo and In Vitro".